UK biotech signs $1bn deal to develop liver disease drugs

Ochre Bio partnering with Germany’s Boehringer Ingelheim on treatments that will harness the organ’s capacity to regenerate
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news